Metabolic Dysfunction in Aging

As we age, we experience a decline in our metabolism and metabolic function.
Researchers at Mayo Clinic have identified the enzyme, called CD38, that is responsible for the decrease in nicotinamide adenine dinucleotide (NAD) during aging, a process that is associated with age-related metabolic decline. Results demonstrated an increase in the presence of CD38 with aging in both mice and humans.
read the article: 
http://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-link-specific-enzyme-to-process-of-metabolic-dysfunction-in-aging/?linkId=25536304

Comments

Popular posts from this blog

First New Drug for Liver Cancer in a Decade: Regorafenib